ATUL SHARMA, M.D.
Ophthalmology Physician · ATLANTA, GA
Individual Active NPI 1104829241
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 766 | 28,606 | $10,332,681 | $2,885,469 | $2,267,098 |
| 2023 | 826 | 24,737 | $10,536,083 | $2,910,292 | $2,288,156 |
| 2022 | 848 | 11,207 | $10,132,916 | $2,867,417 | $2,250,398 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 18,420 | $35 | $27 |
| 92134 | Imaging of retina | 2,004 | $40 | $31 |
| 67028 | Injection of drug into eye | 1,520 | $122 | $96 |
| J0178 | Injection, aflibercept, 1 mg | 1,456 | $814 | $643 |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,455 | $159 | $122 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,080 | $147 | $116 |
| 92014 | Established patient complete exam of visual system | 864 | $126 | $92 |
| J0177 | Injection, aflibercept hd, 1 mg | 360 | $317 | $253 |
| J9035 | Injection, bevacizumab, 10 mg | 287 | $72 | $54 |
| 92012 | Established patient problem focused exam of visual system | 195 | $90 | $68 |
| 92250 | Photography of the retina | 91 | $37 | $27 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 70 | $168 | $103 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 054123 | GA |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | 054123 | GA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Georgia
- NPI 1023888252
- NPI 1740267806
- NPI 1700840147
- NPI 1275039638
- NPI 1134412877
- NPI 1902913429
- NPI 1558637512
- NPI 1821052077
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.